semaglutide novo nordisk announced headline results from STEP UP, a phase IIIb trial investigating subcutaneous 7.2 mg for obesity Novo Nordisk takes legal action

The performance benefit in the gym translates directly to better muscle preservation during a deficit

Recognizing the Signs of a Degraded Peptide Even with the best practices, it's wise to know the warning signs

Phentermine may even require honest conversations regarding anxiety, caffeine intake, and work schedules

Notably, large meta-analyses and collaborative trial datasets have demonstrated no excess risk of severe hypoglycemia, major adverse events, or treatment discontinuation with combination therapy compared with either class alone [11, 28,29,30], supporting the safety and tolerability of combined use in diverse populations